# FDA Inspection 960769 - Biomat USA Inc - February 04, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b3f77dfd-fa29-4848-adf2-c24b99e85c3e
Source feed: FDA_Inspections

> FDA Inspection 960769 for Biomat USA Inc on February 04, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 960769
- Company Name: Biomat USA Inc
- Inspection Date: 2016-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1251500 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7fa8c396-6ee0-48ad-990f-b00ea5bc0dac)
- [FDA Inspection 1251500 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/74b68a58-481b-4f58-a0d9-50bdb9344d51)
- [FDA Inspection 1044110 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/02ddb21d-494a-4250-a549-609251982b3c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/494348ad-28dd-499b-aff6-761a493babe2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d